HLS Therapeutics Inc. (TSX:HLS)
4.690
-0.030 (-0.64%)
Jan 20, 2026, 4:00 PM EST
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 146.67 million as of January 20, 2026. Its market cap has increased by 16.50% in one year.
Market Cap
146.67M
Enterprise Value
207.00M
Revenue
77.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.69
Market Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 146.67M, a decrease of -53.86%. That is a compound annual growth rate of -9.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 147.61M | -2.07% |
| Dec 31, 2025 | 150.74M | 20.64% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |